Epstein-Barr Virus (EBV), IgA, Serum
Method Description Describes how the test is performed and provides a method-specific reference
Epstein-Barr virus-infected substrate cells are reacted with dilutions of serum from the patient. IgA antibodies present in the serum that react with the viral capsid antigen expressed in the infected cells are measured by the indirect immunofluorescence test.(Neel HB 3d, Pearson GR, Taylor WF: Antibodies to Epstein-Barr virus in patients with nasopharyngeal carcinoma and in comparison groups. Ann Otol Rhinol Laryngol 1984;93:477-482)
Supplemental Report Indicates whether the report includes an additional document with charts, images or other enriched information
Day(s) and Time(s) Test Performed Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.
Wednesday; 9 a.m.